MM-102 - CAS 1417329-24-8
Catalog number: 1417329-24-8
Category: Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
C35H49F2N7O4
Molecular Weight:
669.8
COA:
Inquire
Targets:
HMTase
Description:
MM-102, as a MLL1 mimetic, shows high binding affinities to WDR5 with IC50 of 2.9 nM and Ki of < 1 nM.
Publictions citing BOC Sciences Products
  • >> More
Purity:
>98%
Synonyms:
HMTase Inhibitor IX
MSDS:
Inquire
1.Morphometric and meristic characteristics of the goldside loach Sabanejewia balcanica (Cobitidae) in Central Croatia.
Delić A1, Kucinić M, Bucar M, Lazar B, Mrakovcić M. Folia Biol (Krakow). 2003;51 Suppl:33-8.
We studied sixteen morphometric and eight meristic characteristics of forty-five goldside loaches from two rivers in central Croatia, the Bijela and the Petrinjcica, belonging to the Sava River basin. We found significant differences (P<0.01) in all the morphometric characteristics of the populations from these two rivers. While the mean total length (TL) of the goldside loache population from Petrinjcica (mean TL = 60.4 mm, min-max = 52.8 - 70.2 mm) is comparable with TL in other populations described in Europe, individuals from the Bijela seem to be significantly larger (mean TL = 91.8 mm; min-max = 76.4 mm- 102.4 mm) and are among the longest specimens in Europe. Although we can not be sure if this is a result of phenotype variability or some specific taxonomic quality, the position of the Bijela on the old isolated massif of Mt Papuk may have led to the specific morphometric characteristics of this goldside loach population.
2.Epigenetic regulation of glucose-stimulated osteopontin (OPN) expression in diabetic kidney.
Cai M1, Bompada P2, Atac D2, Laakso M3, Groop L4, De Marinis Y5. Biochem Biophys Res Commun. 2016 Jan 1;469(1):108-13. doi: 10.1016/j.bbrc.2015.11.079. Epub 2015 Nov 22.
Diabetes nephropathy (DN) is the leading cause of end stage renal disease and it affects up to 40% of diabetic patients. In addition to hyperglycemia, genetic factors are thought to contribute to the development of DN, but few if any genetic factors have been convincingly linked to DN. Other possible mechanisms may involve epigenetic regulation of glucose-stimulated gene activity which was suggested to explain long-term effects of poor glycemic control on risk of diabetic complications, often referred to as metabolic memory. Osteopontin (OPN) is one of the genes upregulated in kidneys from diabetic mouse models as well as humans with DN, and suggested to play an important role in the pathogenesis of DN. In this study, we demonstrated that OPN gene expression is upregulated in the kidneys of a hyperglycemia diabetes mouse model SUR1-E1506K, and glucose-stimulated OPN gene expression is strongly associated with increases in activating histone marks H3K9ac, H3K4me1 and H3K4me3 and decrease in inactivating mark H3K27me3 in the promoter region of OPN gene.
3.High-affinity, small-molecule peptidomimetic inhibitors of MLL1/WDR5 protein-protein interaction.
Karatas H1, Townsend EC, Cao F, Chen Y, Bernard D, Liu L, Lei M, Dou Y, Wang S. J Am Chem Soc. 2013 Jan 16;135(2):669-82. doi: 10.1021/ja306028q. Epub 2012 Dec 27.
Mixed lineage leukemia 1 (MLL1) is a histone H3 lysine 4 (H3K4) methyltransferase, and targeting the MLL1 enzymatic activity has been proposed as a novel therapeutic strategy for the treatment of acute leukemia harboring MLL1 fusion proteins. The MLL1/WDR5 protein-protein interaction is essential for MLL1 enzymatic activity. In the present study, we designed a large number of peptidomimetics to target the MLL1/WDR5 interaction based upon -CO-ARA-NH-, the minimum binding motif derived from MLL1. Our study led to the design of high-affinity peptidomimetics, which bind to WDR5 with K(i) < 1 nM and function as potent antagonists of MLL1 activity in a fully reconstituted in vitro H3K4 methyltransferase assay. Determination of co-crystal structures of two potent peptidomimetics in complex with WDR5 establishes their structural basis for high-affinity binding to WDR5. Evaluation of one such peptidomimetic, MM-102, in bone marrow cells transduced with MLL1-AF9 fusion construct shows that the compound effectively decreases the expression of HoxA9 and Meis-1, two critical MLL1 target genes in MLL1 fusion protein mediated leukemogenesis.
4.The anatomy of proximal femoral autografts for pelvic reconstruction: a cadaveric study.
Wang S1, Xiong J, Zhan C, Wang A, Chen Y, Jiang Q, Qiu Y. Surg Radiol Anat. 2012 May;34(4):305-9. doi: 10.1007/s00276-011-0914-7. Epub 2011 Dec 3.
PURPOSE: One important reconstruction procedure following pelvic tumor resection is ipsilateral femoral autograft reconstruction in which the autograft is transposed onto the defect and a conventional total hip replacement is implanted in the autograft. The purpose of this study is to provide anatomical evidence for this reconstruction by measurement of proximal femoral autografts.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related HMTase Products


CAS 1271738-59-0 MI-3

MI-3
(CAS: 1271738-59-0)

MI-3 (Menin-MLL Inhibitor) is a potent menin-MLL interaction inhibitor with IC50 of 648 nM.

CAS 1320288-17-2 UNC0646

UNC0646
(CAS: 1320288-17-2)

UNC-0646 is a novel G9a inhibitor with excellent potency in a variety of cell lines and excellent separation of functional potency versus cell toxicity.

CAS 1197196-48-7 UNC0224

UNC0224
(CAS: 1197196-48-7)

The methylation of lysine residues on histones plays a central role in determining euchromatin structure and gene expression. The histone methyltransferase (HMT...

UNC0642
(CAS: 1481677-78-4)

UNC0642 is a potent, selective inhibitor of G9a/GLP with improved PK properties.

XY1
(CAS: 1624117-53-8)

XY1 is a close analog of SGC707 that is completely inactive against PRMT3 at concentrations as high as 100 µM. It is intended to be used as a negative control f...

SGC2085 HCl
(CAS: 1821908-49-9)

SGC2085, also called as GTPL9259, is a potent and selective Coactivator Associated Arginine Methyltransferase 1 (CARM1) Inhibitor with an IC50 of 50 nM and more...

CAS 1906920-28-2 BAY-598 R-isomer

BAY-598 R-isomer
(CAS: 1906920-28-2)

BAY-598 R-isomer is the R-isomer of BAY589 which is a potent, peptide-competitive chemical probe for SET and MYND domain-containing protein 2 (SMYD2), IC50 valu...

CAS 1238673-32-9 UNC0321

UNC0321
(CAS: 1238673-32-9)

UNC0321 is the first G9a inhibitor with picomolar potency and the most potent G9a inhibitor to date. Protein lysine methyltransferase G9a, which catalyzes methy...

CAS 1314241-44-5 UNC 669

UNC 669
(CAS: 1314241-44-5)

(5-Bromopyridin-3-yl)(4-(pyrrolidin-1-yl)piperidin-1-yl)methanone is a selective inhibitor of malignant brain tumor (MBT).

CAS 6398-98-7 Amodiaquin dihydrochloride dihydrate

Amodiaquin dihydrochloride dihydrate
(CAS: 6398-98-7)

Amodiaquine, a 4-aminoquinoquinoline compound, has is a histamine N-methyltransferase inhibitor, used as an antimalarial and anti-inflammatory agent been used a...

CAS 1380316-03-9 EPZ004777 hydrochloride

EPZ004777 hydrochloride
(CAS: 1380316-03-9)

EPZ004777 selectively inhibits cellular H3K79 methylation and inhibits expression of key MLL fusion target genes. Following DOT1L inhibition, EPZ004777 selectiv...

MS023
(CAS: 1831110-54-3)

MS023 is a Potent, Selective, and Cell-Active Inhibitor of Human Type I Protein Arginine Methyltransferases. MS023 displayed high potency for type I PRMTs inclu...

CAS 1561178-17-3 SGC 0946

SGC 0946
(CAS: 1561178-17-3)

SGC0946 is a potent and selective inhibitor of DOT1L, which potently and selectively kills cells containing an MLL translocation. SGC0946 inhibits DOT1L with an...

CAS 1616391-65-1 EPZ015666

EPZ015666
(CAS: 1616391-65-1)

EPZ015666 shows potent cellular activity that blocks symmetric dimethylation of SmD3 and inhibit proliferation of MCL cell lines (Z-138, Granta-519, Maver-1, Mi...

C7280948
(CAS: 587850-67-7)

C7280948 is a novel PRMT1 inhibitor ( IC50=12.75 μM).

CAS 1320288-19-4 UNC-0631

UNC-0631
(CAS: 1320288-19-4)

CAS 1627676-59-8 PFI-2

PFI-2
(CAS: 1627676-59-8)

PFI-2 is a potent, selective, and cell-active lysine methyltransferase SETD7 inhibitor with Ki (app) and IC50 of 0.33 nM and 2 nM, 1000-fold selectivity over ot...

HLCL-61 hydrochloride
(CAS: 1158279-20-9)

The hydrochloride salt form of HLCL-61, an effective inhibitor of PRMT5, could probably useful in the treatment of acute myeloid leukemia.

CAS 1793053-37-8 LLY-507

LLY-507
(CAS: 1793053-37-8)

LLY-507, a lysine N-methyltransferase, is a cell-active, small molecule, and selective inhibitor of Protein-lysine Methyltransferase SMYD2 (IC50 = 15 nM), with ...

CAS 1415800-43-9 UNC1215

UNC1215
(CAS: 1415800-43-9)

UNC1215 is a potent, selective antagonist of L3MBTL3 with cellular activity. UNC1215 has an IC50 of 20 nM and > 100-fold selectivity over 13 HMTs and selected r...

Chemical Structure

CAS 1417329-24-8 MM-102

Quick Inquiry

Verification code

Featured Items